Myocardial stunning refers to myocardium without morphological signs of irreversible damage, which progressively recovers function after an acute episode of ischemia, and may be part of the mechanism of hibernating myocardium. Because stunned myocardium represents viable cardiac tissue, unraveling the molecular mechanisms involving programs of cell survival may open new avenues to salvage dysfunctional cardiac tissue and prevent cell loss in patients with ischemic heart disease. The global aim is to understand the molecular mechanisms underlying the concepts of fully reversible dysfunction and preserved cell viability in stunned myocardium. The first hypothesis is that the complete functional recovery involves the regulated expression of specific genes that function to enhance cell survival and thereby protect myocardial cells from necrosis and apoptosis. The second hypothesis is that the ventricular dysfunction involves an adaptation of genes coding for proteins controlling calcium metabolism. The third hypothesis is that ischemia/reperfusion, which induces stunning and hibernation will result in expression of new genes that are not normally expressed in myocardium, or potentially novel genes not yet described. Experiments will be performed in swine models of stunning, which are relevant to human clinical conditions. The models will be studied at the genomic level and the corresponding protein level. Together, these aims will comprise the first systematic approach toward the identification of the molecular phenotype of stunning in models relevant to clinical conditions. The efforts to better understand the molecular mechanisms of fully reversible dysfunction and preserved cell viability will lead to improved diagnostic and therapeutic strategies in these important clinical syndromes.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL069020-02
Application #
6654185
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
2002-09-01
Project End
2003-08-31
Budget Start
2002-09-01
Budget End
2003-08-31
Support Year
2
Fiscal Year
2002
Total Cost
$296,386
Indirect Cost
Name
University of Medicine & Dentistry of NJ
Department
Type
DUNS #
605799469
City
Newark
State
NJ
Country
United States
Zip Code
07107
Vatner, Dorothy E; Zhang, Jie; Oydanich, Marko et al. (2018) Enhanced longevity and metabolism by brown adipose tissue with disruption of the regulator of G protein signaling 14. Aging Cell :e12751
Guers, John J; Zhang, Jie; Campbell, Sara C et al. (2017) Disruption of adenylyl cyclase type 5 mimics exercise training. Basic Res Cardiol 112:59
Zhang, Jie; Zhao, Xin; Vatner, Dorothy E et al. (2016) Extracellular Matrix Disarray as a Mechanism for Greater Abdominal Versus Thoracic Aortic Stiffness With Aging in Primates. Arterioscler Thromb Vasc Biol 36:700-6
Vatner, Stephen F (2016) Why So Few New Cardiovascular Drugs Translate to the Clinics. Circ Res 119:714-7
Jose Corbalan, J; Vatner, Dorothy E; Vatner, Stephen F (2016) Myocardial apoptosis in heart disease: does the emperor have clothes? Basic Res Cardiol 111:31
Bravo, Claudio A; Vatner, Dorothy E; Pachon, Ronald et al. (2016) A Food and Drug Administration-Approved Antiviral Agent that Inhibits Adenylyl Cyclase Type 5 Protects the Ischemic Heart Even When Administered after Reperfusion. J Pharmacol Exp Ther 357:331-6
Zhao, Xin; Balaji, Poornima; Pachon, Ronald et al. (2015) Overexpression of Cardiomyocyte ?1A-Adrenergic Receptors Attenuates Postinfarct Remodeling by Inducing Angiogenesis Through Heterocellular Signaling. Arterioscler Thromb Vasc Biol 35:2451-9
Pachon, Ronald E; Scharf, Bruce A; Vatner, Dorothy E et al. (2015) Best anesthetics for assessing left ventricular systolic function by echocardiography in mice. Am J Physiol Heart Circ Physiol 308:H1525-9
Vatner, Dorothy E; Yan, Lin; Lai, Lo et al. (2015) Type 5 adenylyl cyclase disruption leads to enhanced exercise performance. Aging Cell 14:1075-84
Sehgel, Nancy L; Sun, Zhe; Hong, Zhongkui et al. (2015) Augmented vascular smooth muscle cell stiffness and adhesion when hypertension is superimposed on aging. Hypertension 65:370-7

Showing the most recent 10 out of 196 publications